There are several different strengths and types of dasatinib

In order to meet the individual treatment needs of different types of patients, Dasatinib has been developed in various specifications. Common dosage forms in the international market include 20mg, 50mg, 70mg, and 100mg tablets. Each specification is designed for the entire film to ensure that the drug is released in the expected manner in the gastrointestinal tract, effectively maintaining its bioavailability and sustained efficacy. The existence of different specifications not only facilitates doctors to formulate appropriate dosage plans according to different disease stages, but also provides some patients with more flexible and controllable treatment options.

For example, the standard starting dose for patients with chronic phase chronic myeloid leukemia (CML) is usually 100 g/day, so the most common prescription specification for dasatinib in many countries is 100 mg tablets, and one tablet per day is enough. For patients with accelerated or blast phase CML and Ph+ acute lymphoblastic leukemia (Ph+ ALL), the recommended dose is 140 mg, usually 70 mg tablets twice daily. In addition, low-dose strengths such as 20 mg and 50 mg are more suitable for use in the initial stage of dose escalation treatment, or when patients experience toxic reactions and need to reduce the dose. Some patients cannot tolerate the standard dose due to liver function, kidney function or comorbid symptoms. Doctors may choose to adjust the daily dose to 60 mg or 80 mg to reduce the incidence of adverse reactions.

The different specifications of dasatinib are also clearly marked on the drug packaging. Each box is usually 60 tablets, and the tablets have different colors and shapes for easy identification. For example, 20 mg usually comes in small round tablets, while 100 mg may come in oval or long strips. Patients should be careful not to mix up the specifications when taking medicines. Especially when changing dosage forms or when pharmacies supply medicines from different sources, they should check the labels and prescriptions clearly.

Although dasatinib comes in a variety of strengths, doctors usually develop individualized dosage plans based on the patient's condition, weight, tolerance, and other drug combinations. Patients are not recommended to change specifications or adjust the dosage without authorization.

Reference materials:https://go.drugbank.com/drugs/DB01254